Larry Page

Dr. Larry Page led five investments in Ag Fund I and is a Board member or observer in four Lewis & Clark Ventures portfolio companies. Larry joined Lewis & Clark in 2016 after working at PierianDx, a start-up specializing in clinical bioinformatics, where he managed several facets of the business including on the laboratory and sales teams. He was also an Entrepreneur-in-Residence at the Nidus Partnership, and he served as Chief Technology Officer of Terra Biologics, a start-up working to commercialize cyanobacteria-based biofertilizers.

Larry enjoys serving as a Preliminary Judge at Arch Grants, as a member of the Selection Committee for Invest Midwest, and as a Young Friend of the Donald Danforth Plant Science Center.

Larry received his PhD in Biochemistry from Washington University in St. Louis, where his thesis focused on the basic mechanics of photosynthetic light harvesting. He conducted undergraduate research on plant molecular biology at the University of Missouri-Columbia, where he received a B.S. in Biochemistry.